Vancouver, BC & Edinburgh, Scotland, Oct. 07, 2025 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce an update from RideScan Ltd (“RideScan”).
RideScan has recently filed its foundational patent application in with United Kingdom Intellectual Property Office, which seeks to protect its unique approach to independent risk scoring and anomaly detection in robotics. This patent-pending technology is intended to further strengthen RideScan’s position as a trusted leader in robotic safety and reliability, enabling applications ranging from mission-level risk assessment to proactive maintenance and certification support.
RideScan is also entering pilot deployments across humanoid, robot, and industrial robotics ecosystems. These pilots are expected to demonstrate RideScan’s ability to provide independent, AI-driven insights into robot health and performance, ensuring safer, more reliable deployments at scale.
“At RideScan, we continue to progress our mission to ensure every robot can be trusted to operate safely and reliably,” said Dr. Nandakumar, CEO of RideScan. “Filing our foundation patent marks a major step in protecting the technology behind that vision, and our upcoming pilots are expected to show how this innovation can help transform the way robots are deployed around the world.”
RideScan is assembling a cohort of 10 organizations to begin integrating RideScan’s API across a range of robotics platforms. Shortlisted candidates include engineers and teams from research institutions and corporations in the robotics field. The purpose of the cohort is to demonstrate RideScan’s ability to reduce downtime by identifying issues before they escalate, enhance operational safety and reliability through independent robotic health checks, and uncover hidden anomalies that are often missed by traditional monitoring systems.
RideScan was recently awarded £50,000 from the Innovate UK Growth Catalyst Early Stage: New Innovators grant, supporting the continued expansion and commercialization of its core technology, with execution beginning on November 1, 2025. RideScan has also received another investment of £40,000 from a Europe-based deep-tech-focused angel syndicate, including research scientists from a subsidiary of a Fortune 500 company specializing in artificial intelligence research.
“We are pleased with RideScan’s advancements, from filing their foundational patent to launching pilot cohorts and securing key grants and investments,” said Shahab Samimi, CEO of Humanoid Global. “We believe that this progress not only fortifies our portfolio’s focus on safe, scalable robotics but also positions RideScan as a cornerstone in enabling trustworthy AI-driven deployments worldwide.”
About Humanoid Global Holdings Corp.
Humanoid Global Holdings Corp. (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF) (“Humanoid Global” or the “Company”) is a publicly traded investment issuer building a portfolio of pioneering companies in the growing humanoid robotics and embodied AI sector, investing in and accelerating their growth. It serves as a global investment platform providing liquidity and access to an actively managed portfolio spanning the value chain of this emerging ecosystem, including advanced software, hardware, and enabling technologies. Led by a team with a proven track record of scaling transformative technologies globally, the Company takes a long-term, partnership-oriented approach. It provides capital and strategic consultation on go-to-market strategies, regulatory pathways, and transaction advisory, while facilitating introductions to customers, suppliers, and strategic partners.
Learn more:
https://www.humanoidglobal.ai/
For further information, please contact:
Shahab Samimi
Chief Executive Officer
finance@humanoidglobal.ai
info@humanoidglobal.ai
(604) 602-0001
CSE:ROBO
OTCQB:RBOHF
FWB:0XM1
ON BEHALF OF MANAGEMENT
Shahab Samimi
Chief Executive Officer
The CSE does not accept responsibility for the adequacy or accuracy of this release.
Forward-Looking Information
This news release contains certain statements that may be considered “forward-looking information” within the meaning of applicable Canadian securities legislation. All statements in this release, other than statements of historical fact, that address events, developments, or performance that the Company expects to occur in the future are forward-looking statements. Forward-looking statements are generally, but not always, identified by words such as “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential,” “targets,” “strategy,” “opportunity,” “will,” “would,” “may,” “could,” or “should,” and similar expressions.
Forward-looking information in this news release includes, but is not limited to, statements regarding: (i) RideScan’s patent application and the protection of its intellectual property; (ii) the expected impact of RideScan’s technology, including its potential applications in risk scoring, anomaly detection, and robotic safety and reliability; (iii) the anticipated outcomes and timing of RideScan’s pilot programs; (iv) the assembly and participation of the RideScan API cohort; (v) the continued commercialization and expansion of RideScan’s technology, including the use of grant funding and investment proceeds; and (vi) the Company’s overall strategy, outlook, and expectations regarding its portfolio and the growth of the humanoid robotics and embodied AI sectors.
Although Humanoid Global believes the expectations and assumptions on which such forward-looking statements are based are reasonable, undue reliance should not be placed on forward-looking statements because the Company can give no assurance they will prove to be correct. Forward-looking statements are not guarantees of future performance and are subject to a variety of known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, among others: delays in or failure to obtain required regulatory approvals; changes in market conditions and technology adoption rates; the availability of capital and financing; operational and execution risks; risks inherent in the early-stage development of emerging technologies; and general economic, business, and political conditions.
Readers are cautioned that the foregoing list is not exhaustive. Additional information about risk factors that could cause actual results to differ materially from forward-looking statements can be found under the Company’s profile on SEDAR+ at http://www.sedarplus.ca. Forward-looking statements in this release are made as of the date hereof and are based on the beliefs, estimates, expectations, and opinions of management at that time. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking statements should circumstances or management’s estimates or opinions change.
